FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023693795> ?p ?o ?g. }

• W2023693795 endingPage "370" @default.
• W2023693795 startingPage "365" @default.
• W2023693795 abstract "Although mizoribine (MZ), which inhibits inosine monophosphate dehydrogenase in the same way as mycophenolate mofetil, recently proved more effective when higher doses were administered than previously approved, neither the optimal dosage nor blood concentration has yet been clarified. We aimed at investigating the effect of high-doses of MZ on prevention of anti-donor antibody (Ab) production and acute Ab-mediated rejection (AMR) on the basis of the pharmacokinetic profile in a pig kidney transplantation model. Group 1 (n = 5) received cyclosporin microemulsion (6 mg/kg) and prednisolone (0.1 mg/kg). Groups 2, 3 and 4 (each n = 5) were treated, respectively, with 30, 10 and 3 mg/kg of MZ in addition to cyclosporin and prednisolone. The incidences of AMR in groups 1, 2, 3 and 4 were 5/5, 1/5, 3/5 and 5/5, respectively. Anti-donor IgG/IgM Ab levels (relative to pretransplantation levels) on day 14 in groups 1, 2, 3 and 4 were 10.3/9.3, 1.8/1.0, 2.3/1.8 and 6.5/3.5, respectively. While only 2 (28.6%) of seven pigs with Cmax > 3 microg/ml during the first 2 weeks had AMR, 7 (87.5%) of eight pigs with Cmax < 3 microg/ml elicited anti-donor Abs and experienced AMR (P = 0.0406). Effective Cmax seemed to be over 3 microg/ml at minimum. Higher doses of MZ efficiently prevented AMR. However, therapeutic drug monitoring is essential before clinical application." @default.
• W2023693795 created "2016-06-24" @default.
• W2023693795 creator A5004777448 @default.
• W2023693795 creator A5041268139 @default.
• W2023693795 creator A5047446260 @default.
• W2023693795 creator A5053926235 @default.
• W2023693795 creator A5058063800 @default.
• W2023693795 creator A5059244382 @default.
• W2023693795 creator A5063951742 @default.
• W2023693795 creator A5070358008 @default.
• W2023693795 creator A5084593362 @default.
• W2023693795 creator A5090820042 @default.
• W2023693795 creator A5091390099 @default.
• W2023693795 date "2007-04-01" @default.
• W2023693795 modified "2023-09-25" @default.
• W2023693795 title "Prophylactic treatment of antibody-mediated rejection with high-dose mizoribine and pharmacokinetic study" @default.
• W2023693795 cites W1963781339 @default.
• W2023693795 cites W1971821439 @default.
• W2023693795 cites W1996369282 @default.
• W2023693795 cites W1999794948 @default.
• W2023693795 cites W2003798082 @default.
• W2023693795 cites W2004026535 @default.
• W2023693795 cites W2004781282 @default.
• W2023693795 cites W2007085368 @default.
• W2023693795 cites W2021397728 @default.
• W2023693795 cites W2022663495 @default.
• W2023693795 cites W2022703205 @default.
• W2023693795 cites W2024124563 @default.
• W2023693795 cites W2030013275 @default.
• W2023693795 cites W2030262480 @default.
• W2023693795 cites W2040667747 @default.
• W2023693795 cites W2044047629 @default.
• W2023693795 cites W2067301997 @default.
• W2023693795 cites W2078438260 @default.
• W2023693795 cites W2082983805 @default.
• W2023693795 cites W2084238186 @default.
• W2023693795 cites W2094473847 @default.
• W2023693795 cites W2110079652 @default.
• W2023693795 cites W2160699440 @default.
• W2023693795 cites W2167078188 @default.
• W2023693795 cites W2322831651 @default.
• W2023693795 cites W4230996310 @default.
• W2023693795 cites W4253539815 @default.
• W2023693795 doi "https://doi.org/10.1111/j.1432-2277.2006.00444.x" @default.
• W2023693795 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17326777" @default.
• W2023693795 hasPublicationYear "2007" @default.
• W2023693795 type Work @default.
• W2023693795 sameAs 2023693795 @default.
• W2023693795 citedByCount "2" @default.
• W2023693795 countsByYear W20236937952017 @default.
• W2023693795 crossrefType "journal-article" @default.
• W2023693795 hasAuthorship W2023693795A5004777448 @default.
• W2023693795 hasAuthorship W2023693795A5041268139 @default.
• W2023693795 hasAuthorship W2023693795A5047446260 @default.
• W2023693795 hasAuthorship W2023693795A5053926235 @default.
• W2023693795 hasAuthorship W2023693795A5058063800 @default.
• W2023693795 hasAuthorship W2023693795A5059244382 @default.
• W2023693795 hasAuthorship W2023693795A5063951742 @default.
• W2023693795 hasAuthorship W2023693795A5070358008 @default.
• W2023693795 hasAuthorship W2023693795A5084593362 @default.
• W2023693795 hasAuthorship W2023693795A5090820042 @default.
• W2023693795 hasAuthorship W2023693795A5091390099 @default.
• W2023693795 hasBestOaLocation W20236937951 @default.
• W2023693795 hasConcept C112705442 @default.
• W2023693795 hasConcept C126322002 @default.
• W2023693795 hasConcept C126894567 @default.
• W2023693795 hasConcept C22979827 @default.
• W2023693795 hasConcept C2776715498 @default.
• W2023693795 hasConcept C2777882293 @default.
• W2023693795 hasConcept C2778033501 @default.
• W2023693795 hasConcept C2909935303 @default.
• W2023693795 hasConcept C2911091166 @default.
• W2023693795 hasConcept C38596361 @default.
• W2023693795 hasConcept C71924100 @default.
• W2023693795 hasConcept C90924648 @default.
• W2023693795 hasConcept C98274493 @default.
• W2023693795 hasConceptScore W2023693795C112705442 @default.
• W2023693795 hasConceptScore W2023693795C126322002 @default.
• W2023693795 hasConceptScore W2023693795C126894567 @default.
• W2023693795 hasConceptScore W2023693795C22979827 @default.
• W2023693795 hasConceptScore W2023693795C2776715498 @default.
• W2023693795 hasConceptScore W2023693795C2777882293 @default.
• W2023693795 hasConceptScore W2023693795C2778033501 @default.
• W2023693795 hasConceptScore W2023693795C2909935303 @default.
• W2023693795 hasConceptScore W2023693795C2911091166 @default.
• W2023693795 hasConceptScore W2023693795C38596361 @default.
• W2023693795 hasConceptScore W2023693795C71924100 @default.
• W2023693795 hasConceptScore W2023693795C90924648 @default.
• W2023693795 hasConceptScore W2023693795C98274493 @default.
• W2023693795 hasIssue "4" @default.
• W2023693795 hasLocation W20236937951 @default.
• W2023693795 hasLocation W20236937952 @default.
• W2023693795 hasOpenAccess W2023693795 @default.
• W2023693795 hasPrimaryLocation W20236937951 @default.
• W2023693795 hasRelatedWork W1965516994 @default.
• W2023693795 hasRelatedWork W2023693795 @default.
• W2023693795 hasRelatedWork W2073120576 @default.
• W2023693795 hasRelatedWork W2368460245 @default.

• next